10:10am ET
Investing
Here’s What Insiders Are Buying to Wrap Up the Year
As the year wound to a close, the most notable insider buying was focused on biotech stocks, but an oil and gas company CEO also returned to the buy window.
Companies
Syros Pharmaceuticals Inc
$0.00
▲ $0.00 (+0.00%) today
Markets closed · 11:40pm ET
Today · % change
About Syros Pharmaceuticals
Syros Pharmaceuticals Inc is a pioneering biopharmaceutical firm based in Cambridge, Massachusetts, dedicated to developing innovative treatments for blood cancers. Its leading products include Tamibarotene, aimed at certain myelodysplastic syndrome patients and acute myeloid leukemia, SY-2101 for acute promyelocytic leukemia, and SY-5609 for advanced solid tumors. The company, established in 2011, collaborates with Incyte Corporation and TMRC Co. Ltd. to advance its research and bring new therapies to market.
